These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1374 related items for PubMed ID: 24854788

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Protein aggregation and its consequences for human disease.
    Dobson CM.
    Protein Pept Lett; 2006; 13(3):219-27. PubMed ID: 16515449
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Amyloidosis: a model of misfolded protein disorder].
    Grateau G, Verine J, Delpech M, Ries M.
    Med Sci (Paris); 2005; 21(6-7):627-33. PubMed ID: 15985206
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Protein aggregation as a cause for disease.
    Scheibel T, Buchner J.
    Handb Exp Pharmacol; 2006; (172):199-219. PubMed ID: 16610361
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Methods and models in neurodegenerative and systemic protein aggregation diseases.
    Brorsson AC, Kumita JR, MacLeod I, Bolognesi B, Speretta E, Luheshi LM, Knowles TP, Dobson CM, Crowther DC.
    Front Biosci (Landmark Ed); 2010 Jan 01; 15(1):373-96. PubMed ID: 20036826
    [Abstract] [Full Text] [Related]

  • 12. Protein misfolding, aggregation and mechanism of amyloid cytotoxicity: An overview and therapeutic strategies to inhibit aggregation.
    Zaman M, Khan AN, Wahiduzzaman, Zakariya SM, Khan RH.
    Int J Biol Macromol; 2019 Aug 01; 134():1022-1037. PubMed ID: 31128177
    [Abstract] [Full Text] [Related]

  • 13. Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange.
    Carulla N, Zhou M, Giralt E, Robinson CV, Dobson CM.
    Acc Chem Res; 2010 Aug 17; 43(8):1072-9. PubMed ID: 20557067
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. New insights into the mechanisms of protein misfolding and aggregation in amyloidogenic diseases derived from pressure studies.
    Foguel D, Silva JL.
    Biochemistry; 2004 Sep 14; 43(36):11361-70. PubMed ID: 15350123
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A brief overview of amyloids and Alzheimer's disease.
    Ow SY, Dunstan DE.
    Protein Sci; 2014 Oct 14; 23(10):1315-31. PubMed ID: 25042050
    [Abstract] [Full Text] [Related]

  • 18. Amyloid by Design: Intrinsic Regulation of Microbial Amyloid Assembly.
    Deshmukh M, Evans ML, Chapman MR.
    J Mol Biol; 2018 Oct 12; 430(20):3631-3641. PubMed ID: 30017921
    [Abstract] [Full Text] [Related]

  • 19. Exposure of Aggregation-Prone Segments is the Requirement for Amyloid Fibril Formation.
    Pramanik S, Ahmad B.
    Curr Protein Pept Sci; 2018 Oct 12; 19(10):1024-1035. PubMed ID: 29779477
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 69.